BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22943816)

  • 1. [Progresses and existed problems on the diagnosis and treatment of Vogt-Koyanagi-Harada disease].
    Zheng YZ
    Zhonghua Yan Ke Za Zhi; 2012 Jun; 48(6):572-6. PubMed ID: 22943816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vogt-koyanagi-harada syndrome.
    Fang W; Yang P
    Curr Eye Res; 2008 Jul; 33(7):517-23. PubMed ID: 18600484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
    Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vogt Koyanagi Harada disease: treatment and visual prognosis.
    Alam M; Iqbal M; Khan BS; Hussain I
    J Coll Physicians Surg Pak; 2013 Oct; 23(10):740-2. PubMed ID: 24112262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vogt-Koyanagi-Harada disease].
    Kjeka O; Krohn J
    Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2195-7. PubMed ID: 16138134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vogt-Koyanagi-Harada disease].
    Bonnet C; Daudin JB; Monnet D; Brézin A
    J Fr Ophtalmol; 2017 Jun; 40(6):512-519. PubMed ID: 28579215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vogt-Koyanagi-Harada disease.
    O'Keefe GA; Rao NA
    Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
    Martin TD; Rathinam SR; Cunningham ET
    Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vogt-Koyanagi-Harada syndrome. Eight cases].
    Alaoui FZ; Benamour S; El Kabli H; Amraoui A
    Rev Med Interne; 2007 Apr; 28(4):250-4. PubMed ID: 17350144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vogt-Koyanagi-Harada disease.
    Damico FM; Kiss S; Young LH
    Semin Ophthalmol; 2005; 20(3):183-90. PubMed ID: 16282153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vogt-Koyanagi-Harada disease.
    Read RW
    Ophthalmol Clin North Am; 2002 Sep; 15(3):333-41, vii. PubMed ID: 12434482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
    Lu S; Taban M
    Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditory and vestibular manifestations of Vogt-Koyanagi-Harada disease.
    Al Dousary S
    J Laryngol Otol; 2011 Feb; 125(2):138-41. PubMed ID: 20880417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features, risk factors and progresses on treatment of recurrent Vogt-Koyanagi-Harada disease].
    Jia SS; Zhao C; Liu XS; Zhang MF
    Zhonghua Yan Ke Za Zhi; 2017 Apr; 53(4):317-320. PubMed ID: 28412807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
    Agarwal M; Ganesh SK; Biswas J
    Ocul Immunol Inflamm; 2006 Dec; 14(6):333-9. PubMed ID: 17162603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and classification of Vogt-Koyanagi-Harada disease.
    Sakata VM; da Silva FT; Hirata CE; de Carvalho JF; Yamamoto JH
    Autoimmun Rev; 2014; 13(4-5):550-5. PubMed ID: 24440284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vogt-Koyanagi-Harada syndrome is an oculo-meningeal syndrome with dermatological and audiological manifestations].
    Pedersen L; Krag S
    Ugeskr Laeger; 2013 Sep; 175(37):2111-2. PubMed ID: 24011207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vogt-Koyanagi-Harada syndrome: review of clinical features.
    Pan D; Hirose T
    Semin Ophthalmol; 2011; 26(4-5):312-5. PubMed ID: 21958180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome.
    Zhang Q; Fan X; Tian M; Han H
    BMC Nephrol; 2020 Jul; 21(1):272. PubMed ID: 32660433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral drug (ipilimumab)-induced vitritis, choroiditis, and serous retinal detachments suggestive of vogt-koyanagi-harada syndrome.
    Wong RK; Lee JK; Huang JJ
    Retin Cases Brief Rep; 2012; 6(4):423-6. PubMed ID: 25389947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.